Find generic entry opportunities
Proactively manage your pharmacy inventory
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Dosage form for treating cardiovascular diseases|
|Abstract:||An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.|
|Inventor(s):||Ayer; Atul D. (Palo Alto, CA), Swanson; David R. (Palo Alto, CA), Kuczynski; Anthony L. (Palo Alto, CA)|
|Assignee:||ALZA Corporation (Palo Alto, CA)|
Patent Claim Types:|
see list of patent claims
|Composition; Delivery; Device;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|United Kingdom||2210266||<disabled in preview>|
|Canada||1317550||<disabled in preview>|
|Switzerland||677609||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.